Cumberland Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: CPIX
Share price (4/6/26): $3.10
Market cap (4/6/26): $49.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Delaying amendment

Shelf registration

Registration of securities for employees

Ownership Filter

Galante Joseph C

Brown Martin S JR

Krogulski Kenneth

News Filter

Reports 31.1% Fourth Quarter 2025 Revenue Growth

Receives FDA Fast Track Designation for Its Ifetroban Duchenne Muscular Dystrophy Program

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement

Reports 12% Year-To-Date Revenue Growth

Announces the Addition of an Established FDA Approved Product to Its Commercial Portfolio

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission